The sales rep study I’d like to see

We’re not sure what to make of a just-released JAMA study* by two professors of, respectively, business management, and economics and psychology, after a highly detailed study of the prescribing practices at academic medical centers. The goal was to compare […]

Read More

PBM hostility to independent pharmacies and small wholesalers

Secondary wholesalers (aka “independent” wholesalers) play a 
unique part of the pharmaceutical distribution business. Although, little loved by the largest manufacturers and wholesalers, their existence is entirely legal—and valuable to the overall healthcare system. These wholesalers function by arbitraging pricing […]

Read More

Hey, what’s this supply chain stuff?

Call it an example of unintended consequences: When Pharmaceutical Commerce began publication in 2005, supply chain issues were relatively unrecognized, and poorly reported. Now, a just-released study sponsored by PhRMA, the industry’s trade association, is entitled The Pharmaceutical Supply Chain: […]

Read More
| 1 Comment

Commercial IT moves to the cloud

We are in the golden age of life sciences. If 2016 is any indication, the industry will continue to push new frontiers in scientific breakthroughs. Profound innovations are occurring in the business/commercial face of the industry as well, especially in […]

Read More

Consultant pharmacists and long-term care 101

Pharmaceutical manufacturers are well-versed in the post-acute care industry. However, a niche role that often goes unnoticed is that of a consultant pharmacist, who contracts with post-acute care providers to deliver expert guidance on the safe, effective and appropriate use […]

Read More